Daiichi Sankyo Company, Limited (OTCMKTS:DSNKY - Get Free Report)'s share price reached a new 52-week low during mid-day trading on Monday . The company traded as low as $24.00 and last traded at $24.55, with a volume of 343567 shares. The stock had previously closed at $25.14.
Daiichi Sankyo Stock Performance
The business's 50 day moving average is $27.21 and its 200 day moving average is $32.11.
Daiichi Sankyo (OTCMKTS:DSNKY - Get Free Report) last posted its earnings results on Friday, January 31st. The company reported $0.22 earnings per share (EPS) for the quarter. Analysts expect that Daiichi Sankyo Company, Limited will post 0.82 EPS for the current year.
Daiichi Sankyo Company Profile
(
Get Free Report)
Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.
Recommended Stories
Before you consider Daiichi Sankyo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Daiichi Sankyo wasn't on the list.
While Daiichi Sankyo currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
